STRESAM

This brand name is authorized in France, Malta, Tunisia, South Africa

Active ingredients

The drug STRESAM contains one active pharmaceutical ingredient (API):

1 Etifoxine UNII NBL8010WH5 - ETIFOXINE HYDROCHLORIDE

Etifoxine is a nonbenzodiazepine anxiolytic agent and acts as a GABAA receptor positive allosteric modulator and as a ligand for translocator proteins. Both mechanisms are conjectured to contribute to its anxiolytic properties. Etifoxine primarily indicated for short-term management of adjustment disorder, specifically instances of situational depression accompanied by anxiety, such as stress-induced anxiety. Read about Etifoxine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STRESAM Capsule		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BX03	Etifoxine	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BX Other anxiolytics
Discover more medicines within N05BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63136857
Country: MT	Medicines Authority	Identifier(s): MA239/00401
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5193021
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/2.6/0072